CRLBF
Price
$0.56
Change
-$0.03 (-5.08%)
Updated
Jun 3 closing price
Capitalization
501.04M
65 days until earnings call
DBCCF
Price
$0.05
Change
-$0.00 (-0.00%)
Updated
Jun 3 closing price
Capitalization
42.97M
Interact to see
Advertisement

CRLBF vs DBCCF

Header iconCRLBF vs DBCCF Comparison
Open Charts CRLBF vs DBCCFBanner chart's image
Cresco Labs
Price$0.56
Change-$0.03 (-5.08%)
Volume$309.68K
Capitalization501.04M
Decibel Cannabis
Price$0.05
Change-$0.00 (-0.00%)
Volume$10.1K
Capitalization42.97M
CRLBF vs DBCCF Comparison Chart
Loading...
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRLBF vs. DBCCF commentary
Jun 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRLBF is a Hold and DBCCF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 04, 2025
Stock price -- (CRLBF: $0.56 vs. DBCCF: $0.05)
Brand notoriety: CRLBF and DBCCF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CRLBF: 58% vs. DBCCF: 10%
Market capitalization -- CRLBF: $501.04M vs. DBCCF: $42.97M
CRLBF [@Pharmaceuticals: Other] is valued at $501.04M. DBCCF’s [@Pharmaceuticals: Other] market capitalization is $42.97M. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.74B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRLBF’s FA Score shows that 0 FA rating(s) are green whileDBCCF’s FA Score has 0 green FA rating(s).

  • CRLBF’s FA Score: 0 green, 5 red.
  • DBCCF’s FA Score: 0 green, 5 red.
According to our system of comparison, DBCCF is a better buy in the long-term than CRLBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRLBF’s TA Score shows that 4 TA indicator(s) are bullish.

  • CRLBF’s TA Score: 4 bullish, 6 bearish.

Price Growth

CRLBF (@Pharmaceuticals: Other) experienced а -14.39% price change this week, while DBCCF (@Pharmaceuticals: Other) price change was +15.63% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +72.19%. For the same industry, the average monthly price growth was +14.40%, and the average quarterly price growth was +61.50%.

Reported Earning Dates

CRLBF is expected to report earnings on Aug 08, 2025.

DBCCF is expected to report earnings on Apr 22, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+72.19% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRLBF($501M) has a higher market cap than DBCCF($43M). DBCCF YTD gains are higher at: 6.445 vs. CRLBF (-38.166). DBCCF has higher annual earnings (EBITDA): 6.05M vs. CRLBF (-16.73M). CRLBF has more cash in the bank: 88.8M vs. DBCCF (3.87M). DBCCF has less debt than CRLBF: DBCCF (49.3M) vs CRLBF (678M). CRLBF has higher revenues than DBCCF: CRLBF (822M) vs DBCCF (89.8M).
CRLBFDBCCFCRLBF / DBCCF
Capitalization501M43M1,165%
EBITDA-16.73M6.05M-277%
Gain YTD-38.1666.445-592%
P/E RatioN/A37.45-
Revenue822M89.8M915%
Total Cash88.8M3.87M2,293%
Total Debt678M49.3M1,375%
FUNDAMENTALS RATINGS
CRLBF vs DBCCF: Fundamental Ratings
CRLBF
DBCCF
OUTLOOK RATING
1..100
5229
VALUATION
overvalued / fair valued / undervalued
1..100
74
Overvalued
43
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9190
PRICE GROWTH RATING
1..100
9457
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

DBCCF's Valuation (43) in the null industry is in the same range as CRLBF (74). This means that DBCCF’s stock grew similarly to CRLBF’s over the last 12 months.

DBCCF's Profit vs Risk Rating (100) in the null industry is in the same range as CRLBF (100). This means that DBCCF’s stock grew similarly to CRLBF’s over the last 12 months.

DBCCF's SMR Rating (90) in the null industry is in the same range as CRLBF (91). This means that DBCCF’s stock grew similarly to CRLBF’s over the last 12 months.

DBCCF's Price Growth Rating (57) in the null industry is somewhat better than the same rating for CRLBF (94). This means that DBCCF’s stock grew somewhat faster than CRLBF’s over the last 12 months.

DBCCF's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for CRLBF (100). This means that DBCCF’s stock grew somewhat faster than CRLBF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRLBF
RSI
ODDS (%)
Bullish Trend 2 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
87%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
84%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
CRLBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DYN13.270.57
+4.49%
Dyne Therapeutics
GCI3.490.04
+1.16%
Gannett Co
ALK50.75-0.15
-0.29%
Alaska Air Group
TACT3.65-0.05
-1.35%
TransAct Technologies
CL90.62-1.31
-1.42%
Colgate-Palmolive Company

DBCCF and

Correlation & Price change

A.I.dvisor tells us that DBCCF and AYTU have been poorly correlated (+21% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that DBCCF and AYTU's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DBCCF
1D Price
Change %
DBCCF100%
+3.02%
AYTU - DBCCF
21%
Poorly correlated
-12.92%
ESALF - DBCCF
15%
Poorly correlated
N/A
CXXIF - DBCCF
2%
Poorly correlated
-8.54%
CRLBF - DBCCF
2%
Poorly correlated
-4.06%
ELTP - DBCCF
-1%
Poorly correlated
+1.04%
More